Givaudan stock trades near a yearly high as margins hold

Givaudan stock combines CHF 3.9 billion in first-half 2025 sales, an EBITDA margin of 17.4%, and 11.6% organic growth, with the Swiss fragrance and flavor group still valued through its earnings mix rather than a single headline catalyst.

Sales rose 11.6 percent

In Givaudan investors materials for 2025, the company reported CHF 3.9 billion in first-half sales and 11.6% organic growth, a comparison that shows how much the base business matters for valuation. The same period also carried a 17.4% EBITDA margin, which leaves little room for investors to ignore profitability when sales accelerate.

That margin matters because organic growth alone does not tell the full story. Givaudan's 2025 half-year figures show a business that is expanding and still keeping a double-digit profitability profile.

Margins stay in focus

The 17.4% EBITDA margin in the first half of 2025 sits alongside CHF 3.9 billion of sales, giving the stock a clear operating reference point for the rest of the year. For investors, the comparison between top-line growth and margin discipline is more useful than any isolated product headline.

Givaudan also said the first half of 2025 included organic growth of 11.6%, which provides a clean year-over-year yardstick. That kind of quantified progression is the key data point for a group whose earnings quality often drives how the market reads the shares.

Fragrance and flavor mix

The company builds its revenue base across flavors and fragrances, and that mix is central to understanding why a CHF 3.9 billion sales figure still carries strategic weight. A higher-margin portfolio tends to reward stable growth more than one-off volume spikes.

Within that framework, the 2025 half-year numbers offer a current business snapshot rather than a theme story. Sales of CHF 3.9 billion, organic growth of 11.6%, and a 17.4% EBITDA margin are the three figures that define the set.

Swiss listing context

Givaudan is listed on the SIX Swiss Exchange, where CHF pricing and a Switzerland-focused investor base make its operating trends more important than broad market noise. The company remains a large-cap consumer-staples-style compounder, but the measurable anchor is still the latest reported margin and sales mix.

Fragrances and flavors

Givaudan's product range is built around fragrances and flavors, which means the reported sales and margin profile are the most relevant numbers for investors rather than a single consumer product. The first-half 2025 figures show how that portfolio translated into CHF 3.9 billion of sales and a 17.4% EBITDA margin.

Stock context in CHF

The shares trade on the SIX Swiss Exchange in CHF, so the latest market reading should always be matched with the company's reporting cadence and margin trend. The most concrete valuation anchor in this article remains the 2025 half-year base of CHF 3.9 billion in sales, 11.6% organic growth, and a 17.4% EBITDA margin.